Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.330
-0.050 (-3.62%)
Mar 6, 2026, 4:00 PM EST - Market closed
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $154.63 million as of March 6, 2026. Its market cap has decreased by -12.14% in one year.
Market Cap
154.63M
Enterprise Value
28.82M
1-Year Change
-12.14%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $154.63M, an increase of 22.63%. That is a compound annual growth rate of 1.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 154.60M | 36.33% |
| Dec 31, 2025 | 113.40M | -39.65% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jyong Biotech | 166.10M |
| Karyopharm Therapeutics | 160.88M |
| Milestone Pharmaceuticals | 160.50M |
| Immunic | 160.47M |
| Rani Therapeutics Holdings | 157.98M |
| Innate Pharma | 151.10M |
| Zentalis Pharmaceuticals | 148.60M |
| Corbus Pharmaceuticals Holdings | 148.41M |